STOCK TITAN

SKYX Platforms (SKYX) S-3 Filings

SKYX NASDAQ

Every S-3 that SKYX Platforms Corp. (SKYX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A S-3 covers the shelf registration that lets an established company sell over time, so if you follow SKYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SKYX filings page.

Rhea-AI Summary

SKYX Platforms Corp. is registering up to 25,250,000 shares of common stock for resale by selling securityholders from time to time after the registration statement becomes effective. The shares were issued in connection with its October 13, 2026 merger with Deako; consideration included cash and 25,000,000 SKYX shares, and SKYX separately issued 250,000 shares to Deako’s broker. SKYX will not receive proceeds from the selling holders’ sales. The registered shares represent approximately 18.28% of common shares outstanding as of October 12, 2026, before the merger closing and issuance.

The covered shares are subject to transfer restrictions expiring in four equal 25% tranches at 12, 15, 18 and 21 months after closing, subject to exceptions. SKYX also reports it is not in compliance with Nasdaq board-independence and audit-committee requirements following the September 26, 2026 death of independent director Efrat L. Greenstein Brayer. The cure period ends at the earlier of the next annual meeting or September 26, 2027; if the meeting occurs before March 25, 2027, compliance must be evidenced by March 25, 2027. Failure to regain compliance would prompt Nasdaq to notify SKYX that its common stock is subject to delisting.

Rhea-AI Summary

SKYX Platforms Corp. proposes a shelf registration to offer up to $200,000,000 of securities. The prospectus registers an aggregate $200,000,000 of common stock, preferred stock, debt securities, depositary shares, warrants, purchase contracts, units and subscription rights to be offered from time to time.

The offering is a shelf registration that permits multiple types and series of securities to be sold in one or more offerings, with terms, amounts and prices to be set in future prospectus supplements. The prospectus states that proceeds treatment will be described in each applicable prospectus supplement.

Rhea-AI Summary

SKYX Platforms Corp. has filed a resale registration covering up to 3,350,000 shares of common stock that may be sold from time to time by existing investors. The shares include 750,000 shares issuable upon conversion of 60,000 shares of Series A-2 Preferred Stock, an estimated 600,000 shares that may be issued as stock dividends on that preferred stock, and 2,000,000 shares issued in a January 2026 private placement at $2.00 per share.

The company will not receive proceeds from any resale of these shares, although it has already received cash from the underlying private placements. The preferred stock carries an 8% annual dividend and ranks senior to common stock in dividends and liquidation, and its conversion and dividend payments in stock could dilute existing common holders and reduce their relative voting power.